CSC’s Senior Director of Education Rachel Saks will speak with Dermatologist and Dermatopathologist Dr. Emily Smith, faculty at University of Missouri-Columbia and head of the multidisciplinary cutaneous oncology and oncodermatology program at Ellis Fischel Cancer Center. They will discuss everything you need to know about advanced non-melanoma skin cancer with a focus on risk factors, the diagnosis process, and treatment options. This program was made possible with generous support by Sanofi and Regeneron.

Cancer Support Community’s Rachel Saks, Senior Director of Education for a talk with Dr. Sandra Cuellar, Clinical Associate Professor in the Department of Pharmacy Practice at the University of Illinois, Chicago College of Pharmacy to learn more about these innovative drugs. They will discuss the role of biologics in cancer treatment, what biosimilar drugs are, and how they are modeled on original biologic drugs.

Immunotherapy is one of the newest treatments in the fight against cancer. Bispecific antibody immunotherapy adds a new dimension that may bring even more hope to cancer patients. Join the Cancer Support Community’s Senior Director of Education, Rachel Saks, MSS, LSW, OSW-C, for a talk with Ian Flinn, MD and learn about this innovative new cancer treatment. Dr. Flinn is the Director of Lymphoma Research at the Sarah Cannon Research Institute. Dr. Flinn also serves as the director for the Sarah Cannon Center for Blood Cancer at Tennessee Oncology and TriStar Centennial Medical Center.

The Cancer Support Community hosted it’s 3rd Annual Utilization Management (UM) Summit on November 16, 2021. This year’s Summit focused on health equity, and featured a keynote address by Dr. Karen Winkfield, Executive Director of the Meharry-Vanderbilt Alliance, and remarks from Dr. Danielle Carnival with the White House Office of Science and Technology Policy. The Summit also featured a focused panel discussion on how the use of UM tools like prior authorization and step therapy may exacerbate health inequities across the healthcare system with panelists:

The Cancer Policy Institute hosted a webinar to address the use of high-deductible health plans and their implications on patients’ access and affordability to care with guest speakers:

Kollet Koulianos, MBA, Vice President of Payer Relations, National Hemophilia Foundation
Cynthia Cox, Vice President, Kaiser Family Foundation
Myra Simon, Principal, Avalere Health

Lisa and Dana, diffuse b-call (DLBCL) survivors, give their advice as patients working with their care teams, support from caregivers, and coping with uncertainty.

Dana, a diffuse large b-cell lymphoma (DLBCL) survivor, explains her journey of survivorship.

“Resources are a little different for the pediatric population,” says our licensed social worker, Beth.  From school needs to lodging, financial support and more, find out how CSC and the Bear Fund help families who are facing the challenges that come when a child is diagnosed with cancer.

Join Cancer Support Community’s Rachel Saks, Senior Director of Education, in a webinar about biomarker testing for non-small cell or small cell lung cancer.  Dr. Sanja Dacic of the University of Pittsburgh Medical Center Presbyterian Hospital will discuss biomarker testing for lung cancer and how it is being used to identify targeted therapy options based on your specific cancer subtype.

In this Quick Guide to Lung Cancer Treatment, you’ll learn what lung cancer is, what its risk factors are, how it is diagnosed, what staging means, and what the two main types of lung cancer are. You’ll also learn how treatment is planned, what common lung cancer treatments are, and what resources are available for learning more.